Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
Federal Circuit reverses IPR decision, invalidates all claims challenged by Finnegan clients DuPont and Archer-Daniels-Midland Federal Circuit reverses IPR decision, invalidates all claims challenged by Finnegan clients DuPont and Archer-Daniels-Midland
17-1977, Fed. Cir.
Experience
Finnegan client AbbVie secures non-institution decisions for Humira® patents Finnegan client AbbVie secures non-institution decisions for Humira® patents
IPR2018-01987, -01988, PTAB, Judges Ankenbrand, Harlow, Mitchell
Experience
Inter partes reexamination ruling affirmed in favor of Finnegan client DuPont Inter partes reexamination ruling affirmed in favor of Finnegan client DuPont
17-1032, -1098, Fed. Cir.
Experience
AbbVie secures four non-institution decisions for Humira® patent AbbVie secures four non-institution decisions for Humira® patent
IPR2017-00822, -00823, -01008, -01009, PTAB, Judges Ankenbrand, Hulse, Mitchell
Experience
PTAB rules in favor of Finnegan client Neste Oil Oyj in IPR proceeding PTAB rules in favor of Finnegan client Neste Oil Oyj in IPR proceeding
IPR2013-00578, PTAB
15-1773, Fed. Cir.
Experience
Lannett Holdings, Inc. v. AstraZeneca AB Lannett Holdings, Inc. v. AstraZeneca AB
IPR2015-01629, -01630, PTAB
Experience
PTAB denies institution of Coalition for Affordable Drugs inter partes review challenges to Biogen patents PTAB denies institution of Coalition for Affordable Drugs inter partes review challenges to Biogen patents
IPR2015-01086, -01136, -01993, PTAB, Judges Gardener-Lane, Katz, Schafer
Experience
REG Synthetic Fuels, LLC v. Neste Oil Oyj REG Synthetic Fuels, LLC v. Neste Oil Oyj
IPR2013-00178; IPR2014-00192, PTAB
Experience
Neste Oil Oyj v. Dynamic Fuels, LLC Neste Oil Oyj v. Dynamic Fuels, LLC
1:12-cv-00662; 1:12-cv-01744, D. Del., Judge Sleet
Experience
District court ruling maintains patent and regulatory protection of Otsuka’s Abilify® District court ruling maintains patent and regulatory protection of Otsuka’s Abilify®
3:07-cv-01000, D.N.J., Judges Cooper, Goodman, Hughes
11-1126, -1127, Fed. Cir., Judges Lourie, Moore, Reyna
Experience
A high-impact result for R&D licensing programs in the pharmaceutical industry A high-impact result for R&D licensing programs in the pharmaceutical industry
0:98-cv-07164; 0:00-cv-07057; 0:05-cv-60158, S.D. Fla., Judge Jordan
03-1354, -1355, -1386, -1387, Fed. Cir., Judges Michel, Lourie, Dyk
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.